Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Rate of chronic health conditions among children in the U.S. increased from 12.8% to 26.6%

The rate of chronic health conditions among children in the U.S. increased from 12.8 percent in 1994 to 26.6 percent in 2006, for conditions such as obesity, asthma and behavior/learning problems, according to a study in the February 17 issue of JAMA.

17 Feb 2010

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

CalciMedica today announced that the US Patent and Trademark Office has issued to CalciMedica US Patent No. 7,645,588, a composition patent involving STIM1, a key component of the calcium release-activated calcium (CRAC) channel. The patent, entitled "Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use," has a priority date of March 4, 2003 and was issued on January 12, 2010.

17 Feb 2010

Merck announces global sales of $27.4 billion for full-year 2009

Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov. 3, 2009 through Dec. 31, 2009.

16 Feb 2010

Meda publishes 2009 year-end report

“The Meda Group expects to achieve sales of about SEK 13,000 million and an EBITDA of about SEK 4,200 million for full-year 2009.”

16 Feb 2010

Lack of comprehensive insurance coverage is barrier for smoking cessation: Study

As a new year and decade begin, many Pennsylvanians have made an important resolution to quit smoking. Wanting to quit is a good first step, but it's not nearly enough. Smoking, we now know, is not just a "habit"; it's a true physical addiction, and, on average, most smokers try at least five times to quit.

16 Feb 2010

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.

16 Feb 2010

People can take simple steps to minimize risk of exposure to allergens during gardening, AAAAI

The beauty of budding plants and bouquet of aromas are sources of satisfaction for many gardeners. For allergy sufferers, though, gardening can be as much a chore as pursuit of passion.

15 Feb 2010

Effective smoking cessation treatments

With the national trend toward quitting smoking flat, psychologists are finding some success with treatments aimed at helping smokers from underserved groups, including racial and ethnic minorities and those with psychiatric disorders.

15 Feb 2010

Hypnosis has potential therapeutic value in children with respiratory disorders

Hypnosis has potential therapeutic value in children with respiratory disorders for alleviating symptoms such as habit cough or unexplained sensations of difficulty breathing and for lessening a child's discomfort during medical procedures.

15 Feb 2010

Ragweed pollen allergy: SLIT safe and effective alternative to injections

An oral allergy treatment administered in drops under the tongue is a safe and effective alternative to injections for adults who are allergic to ragweed pollen, according to a study published today in the Journal of Allergy and Clinical Immunology by allergic disease specialist at Allegheny General Hospital.

15 Feb 2010

Antibodies also contribute to severe dengue virus-induced disease, confirms La Jolla Institute for Allergy & Immunology

A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.

12 Feb 2010

Parents often recognize signs of asthma in their children but delay home treatment: Report

Parents of young children with asthma often recognize signs that their child is about to have an asthma attack but delay home treatment until the attack occurs, researchers at Washington University School of Medicine in St. Louis report.

12 Feb 2010

Measures to tackle school avoidance in children

Children and adolescents who refuse to attend school should not be given doctors' sick notes. In the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107[4]), child and adolescent psychiatrist Martin Knollmann and colleagues explain the causes of school avoidance and describe measures to tackle the problem.

12 Feb 2010

PARI Pharma commences enrollment in L-CsA Phase 2b efficacy study

PARI Pharma has enrolled the first patient in its Phase 2b clinical trial studying inhaled liposomal cyclosporine A (L-CsA) delivered via a customized Investigational eFlow Nebulizer System. The multinational study is investigating the safety and efficacy of PARI's L-CsA formulation. In previous clinical trials, reactions from physicians and lung transplant recipients to PARI's drug-device combination were encouraging.

11 Feb 2010

FDA grants approval for Abbott's antiretroviral medication Norvir

Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir ® (ritonavir). The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it more convenient for patients.

11 Feb 2010

Boston Scientific combines Cardiovascular Group and Cardiac Rhythm Management Group

Boston Scientific Corporation today announced a series of management changes and restructuring initiatives designed to strengthen the Company and position it for long-term success.

11 Feb 2010

MHQP: Massachusetts primary care physicians achieve measurable improvements in health care quality

Massachusetts primary care physicians continue to achieve measurable improvements in important aspects of health care quality as reported by Massachusetts Health Quality Partners (MHQP). Today, the organization released its sixth annual Quality Insights: Clinical Quality in Primary Care report, comparing the performance of more than 150 medical groups across the state.

11 Feb 2010

Asthma News and Research

Further Reading

Rate of chronic health conditions among children in the U.S. increased from 12.8% to 26.6%

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

Merck announces global sales of $27.4 billion for full-year 2009

Meda publishes 2009 year-end report

Lack of comprehensive insurance coverage is barrier for smoking cessation: Study

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

People can take simple steps to minimize risk of exposure to allergens during gardening, AAAAI

Effective smoking cessation treatments

Hypnosis has potential therapeutic value in children with respiratory disorders

Ragweed pollen allergy: SLIT safe and effective alternative to injections

Antibodies also contribute to severe dengue virus-induced disease, confirms La Jolla Institute for Allergy & Immunology

Parents often recognize signs of asthma in their children but delay home treatment: Report

Measures to tackle school avoidance in children

PARI Pharma commences enrollment in L-CsA Phase 2b efficacy study

FDA grants approval for Abbott's antiretroviral medication Norvir

Boston Scientific combines Cardiovascular Group and Cardiac Rhythm Management Group

MHQP: Massachusetts primary care physicians achieve measurable improvements in health care quality

Eczema in early childhood may influence behavior and mental health later in life

ExonHit Therapeutics S.A. selected to participate in the European IMI consortium

Eczema can lead to behavioral and psychological problems in children

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News